VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

BSH 2021 | COVID-19 vaccination responses in patients with blood cancers

Paresh Vyas, MRCP, FRCP, FRCPath, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, discusses the response to COVID-19 vaccinations in patients with blood cancers. Compared to the general populace, patients with blood cancers will have different responses to vaccinations, and responses will also differ across various blood cancers. Vaccines tend to be less effective in patients with cancers or those receiving immunosuppressive treatments, as well as patients who receive more aggressive chemotherapy treatments. This interview took place at the 2021 British Society for Haematology Annual Scientific Meeting.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter